Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.

Deng MZ, Sinha T, Lai M, Jiang S, Kong H, Cooper V, Gu M, Perelman J, Zhang C, Hanindya C, Carpio V, Keller P, Jadlowsky JK, Leskowitz R, McKenna S, Four M, Barranco JAJ, Cooper N, Jain A, Haines K, Gohil M, Garcia-Gerique L, Russell A, Kulikovskaya I, Gonzalez V, Fraietta JA, Plesa G, Sheppard NC, Davis MM, Chew A, Hexner E, Frey N, June CH, Svoboda J, Riley JL

Open source

DOI
10.21203/rs.3.rs-8436008/v1
Published
2026 Feb 4
Container
Research square
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-8436008/v1,
  title = {Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.},
  author = {Deng MZ and Sinha T and Lai M and Jiang S and Kong H and Cooper V and Gu M and Perelman J and Zhang C and Hanindya C and Carpio V and Keller P and Jadlowsky JK and Leskowitz R and McKenna S and Four M and Barranco JAJ and Cooper N and Jain A and Haines K and Gohil M and Garcia-Gerique L and Russell A and Kulikovskaya I and Gonzalez V and Fraietta JA and Plesa G and Sheppard NC and Davis MM and Chew A and Hexner E and Frey N and June CH and Svoboda J and Riley JL},
  year = {2026},
  journal = {Research square},
  doi = {10.21203/rs.3.rs-8436008/v1},
  url = {https://doi.org/10.21203/rs.3.rs-8436008/v1}
}

RIS

TY  - JOUR
TI  - Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.
AU  - Deng MZ
AU  - Sinha T
AU  - Lai M
AU  - Jiang S
AU  - Kong H
AU  - Cooper V
AU  - Gu M
AU  - Perelman J
AU  - Zhang C
AU  - Hanindya C
AU  - Carpio V
AU  - Keller P
AU  - Jadlowsky JK
AU  - Leskowitz R
AU  - McKenna S
AU  - Four M
AU  - Barranco JAJ
AU  - Cooper N
AU  - Jain A
AU  - Haines K
AU  - Gohil M
AU  - Garcia-Gerique L
AU  - Russell A
AU  - Kulikovskaya I
AU  - Gonzalez V
AU  - Fraietta JA
AU  - Plesa G
AU  - Sheppard NC
AU  - Davis MM
AU  - Chew A
AU  - Hexner E
AU  - Frey N
AU  - June CH
AU  - Svoboda J
AU  - Riley JL
PY  - 2026
JO  - Research square
DO  - 10.21203/rs.3.rs-8436008/v1
UR  - https://doi.org/10.21203/rs.3.rs-8436008/v1
ER  - 

APA

MZ, D., T, S., M, L., S, J., H, K., V, C., M, G., J, P., C, Z., C, H., V, C., P, K., JK, J., R, L., S, M., M, F., JAJ, B., N, C., A, J., K, H., M, G., L, G., A, R., I, K., V, G., JA, F., G, P., NC, S., MM, D., A, C., E, H., N, F., CH, J., J, S., & JL, R. (2026). Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.. Research square. https://doi.org/10.21203/rs.3.rs-8436008/v1

Source records